FDA Authorizes Gohibic (vilobelimab) Injection for the Treatment of COVID-19

Upcoming Events

Pneumococcal Vaccine Update for Physicians and Clinicians – April 30

Please join us for a pneumococcal vaccine update webinar on Tuesday, April 30, noon - 1:00 p.m. and hear from Lynn Fisher, MD, family physician and Gretchen Homan, MD, pediatrician, who will provide updates impacting adult pneumococcal vaccine recommendations for adult and pediatric patients, respectively and Monica Pando, RN, VFC coordinator, who will discuss navigating these updates from a clinic perspective.

careLearning Informational Webinar - May 1

In this webinar you will gain practical knowledge of how the careLearning system will help you organize and manage your education. careLearning is non-profit member service of The Kansas Hospital Association and over 40 other state hospital associations.

KARQM Education Program - May 2

The Kansas Association of Risk and Quality Management was created to promote the delivery of quality health care and the practice of risk management in Kansas health care facilities. Membership includes risk and quality management professionals in health care facilities or health-related organizations.

Educational Webinar: How Do Your Hospital Finances Measure Up? – May 2

Join Healthworks and KHA for an educational session at 2:00 p.m. on May 2 to learn how to utilize QHis financial benchmarking tool effectively. Shannan Flach, vice president health care finance and reimbursement and Sally Othmer, vice president data and strategic analytics will be joined by Wes Garrison, founder, Databasically to walk through the tool including the easy-upload process, reviewing the QHi financial measures available and to demonstrating how to run and schedule reports.

Opioid Educational Webinar: Partnering to Increase Access to SUD Treatment – May 3

Please join us on May 3 to hear how hospitals and communities are partnering to increase access to substance use disorder treatment and harm reduction. The program has been approved for 1.0 contact hours of continuing nursing education and pending approval for 1.0 contact hours of continuing pharmacy education. There is no charge to attend as this program is funded through a grant from our partners at DCCCA.

Current Report Articles

‹‹ Back To List

FDA Authorizes Gohibic (vilobelimab) Injection for the Treatment of COVID-19

(April 7, 2023) – The Food and Drug Administration has granted emergency use authorization for the monoclonal antibody vilobelimab (Gohibic—InflaRx NV) for the treatment of hospitalized COVID-19 patients when administered within 48 hours of undergoing invasive mechanical ventilation or extracorporeal membrane oxygenation (artificial life support). The injection targets a portion of the immune system that is believed to have an effect on the inflammation that triggers disease progression in COVID-19 patients. A late-stage trial found that patients treated with vilobelimab had a reduced risk of death by day 28 and day 60 of treatment compared with a placebo. InflaRx is currently in talks with the FDA about applying for full approval for vilobelimab for this COVID-19 indication. According to the FDA, the recommended dosage is 800 mg administered through I.V. infusion after dilution, injected up to six times during the treatment period. Additional safety information, dosing instructions, and potential side effects can be found in the authorized Fact Sheet for Health Care Providers. Additional information on authorized COVID-19 treatments is available on FDA's Emergency Use Authorization webpage.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News